Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (6 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
2 selected
)
Type
Guidance (220)
Quality standard (0)
Guidance programme
(
3 selected
)
Guidance programme
Antimicrobial prescribing guidelines (2)
Clinical guidelines (45)
Diagnostics guidance (6)
Health technology evaluations (3)
Highly specialised technologies guidance (8)
Interventional procedures guidance (63)
Medical technologies guidance (27)
NICE guidelines (57)
Public health guidelines (7)
Social care guidelines (9)
Technology appraisal guidance (187)
Apply filters
Showing 1 to 10 of 220
Sort by
Date
Title
Apply sorting
Last updated date between 1/4/2021 and 31/3/2023
Remove Last updated date between 1/4/2021 and 31/3/2023 filter
Type: Guidance
Remove Type: Guidance filter
Type: Quality standard
Remove Type: Quality standard filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Medical technologies guidance
Remove Guidance programme: Medical technologies guidance filter
Guidance programme: Diagnostics guidance
Remove Guidance programme: Diagnostics guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Finerenone for treating chronic kidney disease in type 2 diabetes
TA877
23 March 2023
23 March 2023
Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancer
TA876
22 March 2023
22 March 2023
Eptinezumab for preventing migraine
TA871
1 March 2023
1 March 2023
Cannabidiol for treating seizures caused by tuberous sclerosis complex
TA873
1 March 2023
1 March 2023
Polatuzumab vedotin in combination for untreated diffuse large B-cell lymphoma
TA874
1 March 2023
1 March 2023
Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies
TA872
28 February 2023
28 February 2023
Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma
TA870
22 February 2023
22 February 2023
Mitapivat for treating pyruvate kinase deficiency (terminated appraisal)
TA867
16 February 2023
16 February 2023
Teclistamab for treating relapsed or refractory multiple myeloma after 3 or more therapies (terminated appraisal)
TA869
16 February 2023
16 February 2023
Vutrisiran for treating hereditary transthyretin-related amyloidosis
TA868
15 February 2023
15 February 2023
Current page
1
2
3
…
22
Page
1
of
22
Next page
Results per page
10
25
50
All
Back to top